Health Care/Hospital

Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after covalent or non-covalent BTK inhibitors and BTK degraders was selected for oral presentation ...

2025-04-24 18:38 2261

OMRON Healthcare Donates 4,000 Blood Pressure Monitors and Advances AFib Screening with AI-based Intellisense AFib Technology

- Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May17 Marks World Hypertension Day during May Measurement Month - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (Head Office: Muko,Kyoto Prefecture; hereinafter referred t...

2025-04-24 16:00 2057

Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating

Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health" or "the Company", Stock Code: 1833.HK) announced its first-quarter results for...

2025-04-24 15:30 3505

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

- Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New data on MM-II to be presented this weekend at the OARSI 2025 World Conference on Osteoarthritis - - MM-II recently granted Fast Track Designation ...

2025-04-24 14:31 2168

Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor

LUXEMBOURG, April 23, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering advanced wearable AIoT solutions that seamlessly merge athletic performance monitoring with real-time health insights, is please...

2025-04-24 08:00 2975

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 23, 2025 /PRNewswire/ -- CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing...

2025-04-24 00:00 2726

SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection

A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 23, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers inthe United States, is proud to announce their partnership with Lunit, a global leader in AI-d...

2025-04-24 00:00 2454

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 2025 /PRNewswire/ -- On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeti...

2025-04-23 21:35 2417

Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"

BEIJING, April 23, 2025 /PRNewswire/ -- In March 2025, Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis services through a comprehensive suite of offerings such asTsynth™Gene Synthesis

2025-04-23 17:18 1859

A Breakthrough in Brain Surgery Monitoring: Guarding Lives with Raytron's Thermal Imaging Technology

YANTAI, China, April 23, 2025 /PRNewswire/ -- In high-stakes neurosurgery, gaining real-time insights into cerebral blood flow is vital yet challenging. Conventional indocyanine green (ICG) fluorescence imaging relies on contrast agents and offers limited repeatability. Now, infrared thermography...

2025-04-23 15:20 1943

Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

HANGZHOU, China, April 22, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its first-in-class (FIC), tri-specific agonist targeti...

2025-04-23 15:03 1853

Samsung Biologics reports first quarter 2025 financial results

* Recorded Q1'25 consolidated revenue of KRW 1.3 trillion * Recorded Q1'25 consolidated operating profit of KRW 486.7 billion * Company expected to maintain steady growth momentum in 2025 driven by enhanced operational efficiency and diverse service offerings INCHEON, South Korea, April 23, ...

2025-04-23 14:46 2564

VARON Advocates for Sustainability on Earth Day with Eco-Friendly Oxygen Solutions

NEW YORK, April 22, 2025 /PRNewswire/ -- This Earth Day, VARON is proud to reaffirm its commitment to both respiratory health and environmental responsibility. As a global leader in oxygen concentrator technology, VARON continues to advance sustainable innovation, offerin...

2025-04-23 08:11 3718

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US

*  The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current electroencephalogram technologies *  The FDA has granted authorisation for Minder under its De Novo pathway...

2025-04-23 06:15 1895

WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year

* Firm commitment to tackling climate change in support of United Nations Sustainable Development Goals * Earth Day 2025 - Our Power, Our Planet, Contribute to a sustainable future SHANGHAI, April 22, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Resear...

2025-04-22 16:30 4114

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 3...

2025-04-21 20:30 3646

UK Clinical Study Finds Sky Labs' Smart Ring 'CART-I' More Sensitive Than Apple Watch for AFib Detection

* Published in the international journal Heart Rhythm O2, the clinical study demonstrates that CART-I achieved 84.6% sensitivity – higher than Apple Watch's 69.1% * Sky Labs also recognized with Korea's top tech honor: IR52 Jang Young-sil Award – Prime Minister's Award SEOUL, South Korea, Ap...

2025-04-21 20:00 2299

INTCO Medical Launches New Syntex™ Synthetic Disposable Latex Gloves Featuring Breakthrough Performance Beyond Natural Latex

ZIBO, China, April 21, 2025 /PRNewswire/ -- INTCO Medical ("INTCO" or "the Company"), the world's leading manufacturer of disposable gloves, has announced the global launch of its exclusive patentedSyntex™ Synthetic Disposable Latex Gloves  product. Breaki...

2025-04-21 19:15 2359

Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025

ALAMEDA, Calif. and TAIPEI, April 21, 2025 /PRNewswire/ -- Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary dual-payload antibody-drug conjugate (AD2C) for hepatocellular carcinoma (HCC). The data will be featured at the American Associatio...

2025-04-21 19:00 2046

DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies

SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusive licensing agreement with GC Cell, a gene and cell therapy firm, for the tumor antigen-specific anti...

2025-04-21 15:35 2205
1 ... 43444546474849 ... 308

Week's Top Stories